title: Stimulation of beta3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels.
abstract: We investigated the role of large-conductance Ca(2+)-activated K(+) (BK) channels in beta3-adrenoceptor (beta3-AR)-induced relaxation in rat urinary bladder smooth muscle (UBSM). BRL 37344, a specific beta3-AR agonist, inhibits spontaneous contractions of isolated UBSM strips. SR59230A, a specific beta3-AR antagonist, and H89, a PKA inhibitor, reduced the inhibitory effect of BRL 37344. Iberiotoxin, a specific BK channel inhibitor, shifts the BRL 37344 concentration response curves for contraction amplitude, net muscle force, and tone to the right. Freshly dispersed UBSM cells and the perforated mode of the patch-clamp technique were used to determine further the role of beta3-AR stimulation by BRL 37344 on BK channel activity. BRL 37344 increased spontaneous, transient, outward BK current (STOC) frequency by 46.0 +/- 20.1%. In whole cell mode at a holding potential of V(h) = 0 mV, the single BK channel amplitude was 5.17 +/- 0.28 pA, whereas in the presence of BRL 37344, it was 5.55 +/- 0.41 pA. The BK channel open probability was also unchanged. In the presence of ryanodine and nifedipine, the current-voltage relationship in response to depolarization steps in the presence and absence of BRL 37344 was identical. In current-clamp mode, BRL 37344 caused membrane potential hyperpolarization from -26.1 +/- 2.1 mV (control) to -29.0 +/- 2.2 mV. The BRL 37344-induced hyperpolarization was eliminated by application of iberiotoxin, tetraethylammonium or ryanodine. The data indicate that stimulation of beta3-AR relaxes rat UBSM by increasing the BK channel STOC frequency, which causes membrane hyperpolarization and thus relaxation.
authors.affiliation: Dept. of Pharmaceutical and Biomedical Sciences, South Carolina College of Pharmacy, Univ. of South Carolina, Coker Life Sciences Bldg., Rm. 709, 715 Sumter St., Columbia, SC 29208, USA.
authors.forename: Kiril L
authors.initials: KL
authors.lastname: Hristov
authors.forename: Xiangli
authors.initials: X
authors.lastname: Cui
authors.forename: Sean M
authors.initials: SM
authors.lastname: Brown
authors.forename: Lei
authors.initials: L
authors.lastname: Liu
authors.forename: Whitney F
authors.initials: WF
authors.lastname: Kellett
authors.forename: Georgi V
authors.initials: GV
authors.lastname: Petkov
mesh_terms: D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D051036:Large-Conductance Calcium-Activated Potassium Channels / Q000819:agonists* / Q000378:metabolism; D008297:Male; D008564:Membrane Potentials; D009126:Muscle Relaxation / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects* / Q000378:metabolism; D018408:Patch-Clamp Techniques; D026902:Potassium Channel Blockers / Q000494:pharmacology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D022702:Receptors, Adrenergic, beta-3 / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D001743:Urinary Bladder / Q000187:drug effects* / Q000378:metabolism
chemical_list: D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D004983:Ethanolamines; D051036:Large-Conductance Calcium-Activated Potassium Channels; D026902:Potassium Channel Blockers; D047428:Protein Kinase Inhibitors; D022702:Receptors, Adrenergic, beta-3; D019837:Ryanodine Receptor Calcium Release Channel; C057368:BRL 37344; D017868:Cyclic AMP-Dependent Protein Kinases; D002118:Calcium
references.citation: EMBO J. 2004 Jun 2;23(11):2196-205
references.pmid: 15141163
references.citation: BJU Int. 2004 Feb;93(3):401-9
references.pmid: 14764146
references.citation: Physiol Rev. 2004 Jul;84(3):935-86
references.pmid: 15269341
references.citation: J Urol. 1999 Feb;161(2):680-5
references.pmid: 9915482
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2006 Jun;373(3):183-5
references.pmid: 16736154
references.citation: Am J Physiol Regul Integr Comp Physiol. 2000 Jul;279(1):R60-8
references.pmid: 10896865
references.citation: J Biol Chem. 2004 Aug 27;279(35):36746-52
references.pmid: 15184377
references.citation: Br J Pharmacol. 2004 Jan;141(1):183-93
references.pmid: 14662721
references.citation: J Urol. 2003 Aug;170(2 Pt 1):649-53
references.pmid: 12853849
references.citation: Am J Physiol Regul Integr Comp Physiol. 2001 Nov;281(5):R1699-709
references.pmid: 11641143
references.citation: J Pharmacol Exp Ther. 2007 Oct;323(1):202-9
references.pmid: 17626794
references.citation: J Physiol. 2003 May 15;549(Pt 1):65-74
references.pmid: 12679374
references.citation: BJU Int. 2006 Dec;98(6):1310-4
references.pmid: 17026593
references.citation: J Physiol. 2006 Jan 1;570(Pt 1):13-22
references.pmid: 16210349
references.citation: J Physiol. 2001 Dec 1;537(Pt 2):443-52
references.pmid: 11731577
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):260-7
references.pmid: 15576470
references.citation: Clin Exp Pharmacol Physiol. 2005 Jul;32(7):503-14
references.pmid: 16026507
references.citation: Am J Physiol Cell Physiol. 2001 Mar;280(3):C481-90
references.pmid: 11171567
references.citation: Eur J Pharmacol. 2005 Aug 22;518(2-3):195-202
references.pmid: 16054622
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 1):C110-7
references.pmid: 9252448
references.citation: J Clin Endocrinol Metab. 2005 Oct;90(10):5786-96
references.pmid: 16014404
references.citation: J Biol Chem. 1998 Jun 12;273(24):14920-4
references.pmid: 9614096
references.citation: Eur J Pharmacol. 2000 Sep 15;404(1-2):231-8
references.pmid: 10980283
references.citation: Eur J Pharmacol. 2007 Nov 14;573(1-3):184-9
references.pmid: 17632099
references.citation: J Gen Physiol. 1988 Aug;92(2):145-59
references.pmid: 2459299
references.citation: Br J Pharmacol. 2006 Feb;147 Suppl 2:S41-55
references.pmid: 16465183
references.citation: Neurourol Urodyn. 2007;26(6):752-6
references.pmid: 17600372
references.citation: Isr Med Assoc J. 2007 Mar;9(3):143-6
references.pmid: 17402321
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2002 Sep;366(3):198-203
references.pmid: 12172701
references.citation: Am J Physiol Regul Integr Comp Physiol. 2001 May;280(5):R1427-33
references.pmid: 11294764
references.citation: J Smooth Muscle Res. 2000 Feb;36(1):21-32
references.pmid: 10830475
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2006 Jul;373(4):300-9
references.pmid: 16736152
references.citation: Urol Clin North Am. 2007 Nov;34(4):619-30, viii
references.pmid: 17983901
references.citation: J Physiol. 2007 Jul 15;582(Pt 2):489-506
references.pmid: 17363382
references.citation: Br J Pharmacol. 1999 Feb;126(3):819-25
references.pmid: 10188996
references.citation: Pflugers Arch. 1981 Aug;391(2):85-100
references.pmid: 6270629
references.citation: J Urol. 2001 Jan;165(1):240-4
references.pmid: 11125417
references.citation: J Urol. 2001 Jul;166(1):335-40
references.pmid: 11435896
references.citation: Biol Res. 2004;37(4):521-5
references.pmid: 15709678
references.citation: J Pharmacol Exp Ther. 1999 Mar;288(3):1367-73
references.pmid: 10027879
references.citation: Pharmacol Rev. 2004 Dec;56(4):581-631
references.pmid: 15602011
references.citation: J Urol. 1998 Jun;159(6):2197-201
references.pmid: 9598569
references.citation: BJU Int. 2005 Aug;96(3):428-33
references.pmid: 16042743
references.citation: Am J Physiol Cell Physiol. 2005 Jun;288(6):C1255-63
references.pmid: 15677377
references.citation: J Urol. 2002 Oct;168(4 Pt 1):1621-5
references.pmid: 12352468
references.citation: Br J Pharmacol. 1997 Dec;122(8):1720-4
references.pmid: 9422819